A large, multicenter, sham-controlled trial in heart failure showed no benefit at all from stem cell delivery on the primary
Negative Stem Cell Results in HF May Still Have Promise: DREAM-HF

besthealthtale.com
Home ยป
A large, multicenter, sham-controlled trial in heart failure showed no benefit at all from stem cell delivery on the primary
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The European Medicines Agency (EMA) continues
A significant number of non-Hodgkin lymphoma (NHL) patients in a Penn Medicine-initiated clinical trial continue to be in remission five